Herpes med does not cut HIV transmission riskJanuary 21st, 2010 - 2:27 pm ICT by ANI
London, Jan 21 (ANI): Acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2, a new study has found.
Published in the New England Journal of Medicine, the study took place at 14 sites in seven countries in eastern and southern Africa (Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda and Zambia).
Around 9 in 10 people with HIV infection also have HSV-2 infection. Most people who are infected with HSV-2 do not know they have the virus because symptoms can be mild or absent. HSV-2 infection can cause recurrent sores and breaks in the skin of the genital region, which can be mild and often go unnoticed. HSV-2 infection also attracts immune cells called CD4 T-cells to the genital region, which HIV uses to establish or pass infection.
The Partners in Prevention HSV/HIV Transmission Study, which was led by the University of Washington in Seattle and funded by the Bill & Melinda Gates Foundation, was conducted among 3,408 African HIV serodiscordant couples, in which one partner had HIV and the other did not. In all the couples, the partner who had HIV also had HSV-2 infection. (ANI)
- Herpes drug does not cut HIV transmission risk - May 09, 2009
- Genital herpes vaccine ineffective in women: Study - Oct 01, 2010
- Herpes vaccine edges closer to reality - Jun 16, 2010
- Why even treated genital herpes sores boost the risk of HIV infection - Aug 03, 2009
- Antiretroviral therapy tied to decreased HIV transmission risk - May 27, 2010
- New discovery may lead to treatment for genital herpes infection - Jan 23, 2010
- Just four out of ten patients know they have genital herpes - Apr 12, 2011
- Study associates herpes to Alzheimer's disease - Apr 05, 2011
- Why circumcision cuts HIV risk - Nov 24, 2009
- Circumcision Lowers Chances Of HPV Risk In Women, Study Says - Jan 09, 2011
- Herpes drug 'can delay' HIV progression - Feb 15, 2010
- Kissing 'poses herpes risk' - Aug 17, 2009
- New herpes vaccine shows promise - Mar 12, 2010
- Condoms use linked to reduced risk of contracting herpes simplex virus 2 - Jul 14, 2009
- Scientists unravel herpes virus protein structure - Jul 27, 2010
Tags: acyclovir, england journal of medicine, herpes, herpes simplex virus, hiv, hiv infection, hiv serodiscordant, hiv transmission, hsv 2, immune cells, jan 21, journal of medicine, london jan, melinda gates foundation, new england journal, new england journal of medicine, risk of hiv, southern africa, t cells, transmission study